BioSpace News Archive

BriaCell Therapeutics Corp. announces that it has filed a provisional patent application with the U.S. Patent and Trademark Office outlining certain features thought to expand the clinical applications of BriaCell’s genetically engineered whole-cell immunotherapies to those of infectious diseases including the SARS-CoV-2 virus that causes Coronavirus Disease 2019.

The KD Pharma Group and its partner, SLA Pharma, announced that its new drug candidate EPAspire™ is shortly entering clinical trials as a promising candidate to treat patients with symptoms of the novel coronavirus infection.

CareDx, Inc., a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced a biopharma research partnership for AlloCell.

IMMUNOPRECISE ANTIBODIES LTD., a global leader in therapeutic antibody discovery and development, announced that it, through its subsidiary Talem Therapeutics, has entered into a research license agreement with Janssen Research & Development, LLC, providing Janssen exclusive access to a panel of novel, monoclonal antibodies against an undisclosed target.

Invacare Corporation will participate in the 19th Annual Needham Healthcare Conference where the company’s management will provide a business update and share preliminary financial results for the first quarter ended March 31, 2020.

Theratechnologies Inc., a commercial-stage biopharmaceutical company, announced its financial results for the first quarter ended February 29, 2020.

Intensity Therapeutics announced it has entered into a clinical trial collaboration agreement with Bristol Myers Squibb Company.

Health Canada approves Quat-Shot™, a hard surface disinfectant expected to INACTIVATE the SARS-CoV-2 virus, the virus that causes COVID-19 or coronavirus, a deadly respiratory virus and cause of current global pandemic

ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, announced that it has received $938,000 in support from the federal government under the Paycheck Protection Program.

Micron Medical announced that it will host a webinar entitled “The Protect PNS for OAB: A Wireless Uro-Stimulation Injectable Technology,” on Wednesday, April 29, 2020 at 5pm Eastern Time.